fluorescein 5-isothiocyanate structure
|
Common Name | fluorescein 5-isothiocyanate | ||
---|---|---|---|---|
CAS Number | 27072-45-3 | Molecular Weight | 389.381 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 708.6±60.0 °C at 760 mmHg | |
Molecular Formula | C21H11NO5S | Melting Point | >360ºC(lit.) | |
MSDS | Chinese USA | Flash Point | 382.4±32.9 °C | |
Symbol |
GHS08 |
Signal Word | Danger |
Use of fluorescein 5-isothiocyanate5(6)-FITC (Fluorescein isothiocyanate) is an amine-reactive derivative of fluorescein dye that has wide-ranging applications as a label for antibodies and other probes, for use in fluorescence microscopy, flow cytometry and immunofluorescence-based assays such as Western blotting and ELISA. |
Name | Fluorescein isothiocyanate |
---|---|
Synonym | More Synonyms |
Description | 5(6)-FITC (Fluorescein isothiocyanate) is an amine-reactive derivative of fluorescein dye that has wide-ranging applications as a label for antibodies and other probes, for use in fluorescence microscopy, flow cytometry and immunofluorescence-based assays such as Western blotting and ELISA. |
---|---|
Related Catalog | |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 708.6±60.0 °C at 760 mmHg |
Melting Point | >360ºC(lit.) |
Molecular Formula | C21H11NO5S |
Molecular Weight | 389.381 |
Flash Point | 382.4±32.9 °C |
Exact Mass | 389.035797 |
PSA | 120.44000 |
LogP | 4.00 |
Appearance of Characters | powder |
Vapour Pressure | 0.0±2.3 mmHg at 25°C |
Index of Refraction | 1.754 |
Storage condition | 2-8°C |
Symbol |
GHS08 |
---|---|
Signal Word | Danger |
Hazard Statements | H334 |
Precautionary Statements | P261-P342 + P311 |
Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
Hazard Codes | Xn: Harmful; |
Risk Phrases | R42/43 |
Safety Phrases | S22 |
RIDADR | NONH for all modes of transport |
WGK Germany | 3 |
Imaging of a clinically relevant stroke model: glucose hypermetabolism revisited.
Stroke 46(3) , 835-42, (2015) Ischemic stroke has been shown to cause hypermetabolism of glucose in the ischemic penumbra. Experimental and clinical data indicate that infarct-related systemic hyperglycemia is a potential therapeu... |
|
Surface modifications of silica nanoparticles are crucial for their inert versus proinflammatory and immunomodulatory properties.
Int. J. Nanomedicine 9 , 2815-32, (2014) Silica (SiO₂) nanoparticles (NPs) are widely used in diverse industrial and biomedical applications. Their applicability depends on surface modifications, which can limit potential health problems.To ... |
|
Uptake of neutrophil-derived Ym1 protein distinguishes wound macrophages in the absence of interleukin-4 signaling in murine wound healing.
Am. J. Pathol. 184(12) , 3249-61, (2014) The determination of regenerative wound-healing macrophages as alternatively activated macrophages is currently questioned by the absence of IL-4 in wound tissue. Yet, murine wound tissue expressed hi... |
5-FITC |
Isothiocyanatofluorescein |
5-Isothionatofluorescein |
FITC isomer I |
Fluorescein Isothiosyanate |
fluorescein isothiocyanate isomer 1 |
FITC ISOMER |
EINECS 222-042-0 |
3',6'-Dihydroxy-5-isothiocyanato-3H-spiro[2-benzofurane-1,9'-xanthén]-3-one |
Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 3',6'-dihydroxy-5-isothiocyanato- |
FITC-I |
Fluorescein 5(6)-isothiocyanate |
FITC |
Fluorescein-5-isothiocyanate |
MFCD00005063 |
Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3',6'-dihydroxy-5-isothiocyanato- |
Fluorescein Isothiocyanate |
fluorescein 5-isothiocyanate |
3',6'-Dihydroxy-5-isothiocyanato-3H-spiro[2-benzofuran-1,9'-xanthen]-3-one |
5(6)-FITC |